Lovotibeglogene Autotemcel has 4 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Hydroxyurea, Iron Chelators, Retrovir. Patients taking Lovotibeglogene Autotemcel should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 4
- Major
- 3
Major (3)
- Lovotibeglogene Autotemcel + Hydroxyurea— Discontinue 2 months prior to mobilization and 2 days prior to conditioning. Interaction with mobilization process and L…
- Lovotibeglogene Autotemcel + Iron Chelators— Drug-drug interactions must be considered with mobilization and myeloablative conditioning. Discontinue at least 7 days …
- Lovotibeglogene Autotemcel + Retrovir— Anti-retroviral medications may interfere with manufacturing of LYFGENIA. Discontinue at least one month prior to mobili…